1. Home
  2. CRON vs STGW Comparison

CRON vs STGW Comparison

Compare CRON & STGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRON
  • STGW
  • Stock Information
  • Founded
  • CRON 2012
  • STGW 1980
  • Country
  • CRON Canada
  • STGW United States
  • Employees
  • CRON N/A
  • STGW N/A
  • Industry
  • CRON Medicinal Chemicals and Botanical Products
  • STGW
  • Sector
  • CRON Health Care
  • STGW
  • Exchange
  • CRON Nasdaq
  • STGW Nasdaq
  • Market Cap
  • CRON 707.7M
  • STGW 683.2M
  • IPO Year
  • CRON N/A
  • STGW N/A
  • Fundamental
  • Price
  • CRON $1.79
  • STGW $6.00
  • Analyst Decision
  • CRON Hold
  • STGW Strong Buy
  • Analyst Count
  • CRON 2
  • STGW 6
  • Target Price
  • CRON $3.00
  • STGW $8.75
  • AVG Volume (30 Days)
  • CRON 1.4M
  • STGW 637.4K
  • Earning Date
  • CRON 05-08-2025
  • STGW 04-30-2025
  • Dividend Yield
  • CRON N/A
  • STGW N/A
  • EPS Growth
  • CRON N/A
  • STGW 1724.82
  • EPS
  • CRON 0.11
  • STGW 0.02
  • Revenue
  • CRON $117,615,000.00
  • STGW $2,841,216,000.00
  • Revenue This Year
  • CRON $22.27
  • STGW $4.00
  • Revenue Next Year
  • CRON $7.36
  • STGW $9.51
  • P/E Ratio
  • CRON $16.68
  • STGW $296.50
  • Revenue Growth
  • CRON 34.82
  • STGW 12.43
  • 52 Week Low
  • CRON $1.77
  • STGW $5.29
  • 52 Week High
  • CRON $3.14
  • STGW $8.18
  • Technical
  • Relative Strength Index (RSI)
  • CRON 35.67
  • STGW 43.18
  • Support Level
  • CRON $1.78
  • STGW $6.04
  • Resistance Level
  • CRON $1.84
  • STGW $6.39
  • Average True Range (ATR)
  • CRON 0.06
  • STGW 0.19
  • MACD
  • CRON -0.01
  • STGW 0.00
  • Stochastic Oscillator
  • CRON 4.55
  • STGW 25.47

About CRON Cronos Group Inc. Common Share

Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

About STGW Stagwell Inc.

Stagwell Inc is the challenger holding company built to transform marketing. It delivers scaled creative performance for the world's ambitious brands, connecting culture-moving creativity with a technology to harmonize the art and science of marketing. The company's segments include Integrated Agencies Network; Brand Performance Network; and Communications Network. It generates maximum revenue from the Integrated Agencies Network segment. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: